Isolated sulfite oxidase deficiency is a rare autosomal recessive disorder of the newborn that can be mistaken for neonatal asphyxia. Diffusion-weighted imaging of the brain demonstrates widespread diffusion restriction, and proton magnetic resonance spectroscopy shows an elevated lactate level, a decrease in the ratio of N-acetylaspartate to creatine, and a rise in the ratio of choline to creatine. This precedes severe cystic encephalomalacia and suggests that the energy failure associated with neuronal dysfunction and myelin disintegration occurs early in isolated sulfite oxidase deficiency. (J Child Neurol 2006;21:801—805; DOI 10.2310/7010.2006.00174).
Get full access to this article
View all access options for this article.
References
1.
Johnson JL, Duran M.: Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency, in Scriver CR, Sly WS, Childs B, et al (eds): The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York, McGraw-Hill Professional , 2001, 3163—3177.
2.
Rupar CA, Gillett J., Gordon BA, et al: Isolated sulfite oxidase deficiency. Neuropediatrics1996;27:299—304.
3.
Tan WH, Eichler FS, Hoda S., et al: Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature. [published erratum appears in Pediatrics 2005;116:1615]. Pediatrics2005;116:757—766.
4.
Takeoka M., Soman TB, Yoshii A., et al: Diffusion-weighted images in neonatal cerebral hypoxic-ischemic injury. Pediatr Neurol2002;26: 274—281.
5.
Salvan AM, Chabrol B., Lamourex S., et al: In vivo proton MR spectroscopy in a case of molybdenum cofactor deficiency. Pediatr Radiol1999;29:846—848.
6.
Schaefer PW, Grant PE, Gonzalez RG: Diffusion-weighted MR imaging of the brain. Radiology2000;217:331—345.
7.
Barker PB, Gillard JH: Acute stroke: Evaluation with serial proton magnetic resonance spectroscopic imaging. Radiology1994;192:723— 732.
8.
Alger JR, Frank JA, Bizzi A., et al: Metabolism of human gliomas: Assessment with H 1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology1990;177:633—641.
9.
Mathews PM, Andermann F., Arnold DL, et al: Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology1993;43:2484—2490.
10.
Birken DL, Oldendorf WH: N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev1989;13:23—31.
11.
Gill SS, Small RK, Thomas DG, et al: Brain metabolites as 1H NMR markers of neuronal and glial disorders . NMR Biomed1989;2:196—200.
